Tomorrow's Health: Autism Group Gets High-Tech Help


Story Updated: Jun 17, 2014

One of the world's biggest tech companies is getting involved in autism research.

Also, some products hair stylists use could increase the level of carcinogens in their bloodstreams and some popular cholesterol medications may have unintended side effects.

Google Helps Autism Research

The advocacy group Autism Speaks announced it is partnering with Google to develop the world's largest collection of autism genomes.

The program will use the Google Cloud platform to collect a vast database of genomic sequence information on individuals with the disorder.

A new study finds the lifetime cost of supporting a person with autism spectrum disorder is between $1.4 million and $2.4 million.

Hair Products Dangerous?

New research in the British Medical Journal finds hairdressers who frequently use hair dye on their clients or give them perms have higher amounts of carcinogens in their blood.

The researchers looked at nearly 300 hairdressers. They found levels of the carcinogens in their bloodstreams rose with the number of weekly color treatments and permanents stylists performed.

Statin-Takers Less Active

A new study finds older men who use statins are less physically active than those who don't.

Researchers say men who took the cholesterol-lowering drugs averaged 40 fewer minutes of moderate exercise a week than men who don't take the medications.

Almost one-third of Americans 65 years old and older take statins. Researchers say the decreased activity could be linked to muscle pain caused by the drugs.

Add a comment


Comment: 1000 Characters Left

WWNY TV 7 - News, Weather and Sports for and its affiliated companies are not responsible for the content of comments posted or for anything arising out of use of the above comments or other interaction among the users. We reserve the right to screen, refuse to post, remove or edit user-generated content at any time and for any or no reason in our absolute and sole discretion without prior notice, although we have no duty to do so or to monitor any Public Forum.